Ezekiel Weis

Associate Professor, Faculty of Medicine & Dentistry - Department of Ophthalmology & Visual Science

Contact Overview Publications

Contact

Associate Professor, Faculty of Medicine & Dentistry - Department of Ophthalmology & Visual Science

Email: ezekiel@ualberta.ca

Overview

Area of Study / Keywords

About

Dr. Ezekiel Weis is currently appointed as Associate Professor in the Department of Ophthalmology & Visual Sciences in the Faculty of Medicine & Dentistry.

Featured Publications

Using SHAP Analysis to Detect Areas Contributing to Diabetic Retinopathy Detection

IEEE International Conference on Information Reuse and Integration (IRI). 2022 August; 10.1109/IRI54793.2022.00046

Optimising prediction of early metastasis-free survival in uveal melanoma using a four-category model incorporating gene expression profile and tumour size

Roelofs K.A., Grewal P., Lapere S., Larocque M., Murtha A., Weis E.

BRITISH JOURNAL OF OPHTHALMOLOGY. 2022 May; 10.1136/bjophthalmol-2020-317714

Patient satisfaction with teleophthalmology in ocular oncology

iovs. 2022 May;

Plaque brachytherapy outcome for large choroidal melanomas.

The Association for Research in Vision and Ophthalmology Annual Meeting. 2022 May;

Strabismus post plaque brachytherapy.

The Association for Research in Vision and Ophthalmology Annual Meeting. 2022 May;

Sunlamp use is a risk factor for uveal melanoma: a meta-analysis

Weis E., Aghazadeh H., Roelofs K., Agi J.

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE. 2022 April; 10.1016/j.jcjo.2021.02.041

Open book technique for conjunctival tumors: a surgical approach to the fornix

Agi J., Sia D.I., Weis E.

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA. 2022 January; 85 (2):178-181 10.5935/0004-2749.20220025

The Alberta standardized orbital technique in the management of spheno-orbital meningiomas

Agi J., Badilla J., Steinke D., Mitha A.P., Weis E.

EUROPEAN JOURNAL OF OPHTHALMOLOGY. 2021 September; 31 (5):2686-2691 10.1177/1120672120960332

Anti-VEGF switch therapy from bevacizumab to aflibercept in radiation retinopathy secondary to uveal melanoma

IOVS. 2021 June;

A Predictive Model for Temporal Artery Biopsy in the Setting of Suspected Giant Cell Arteritis: A Validation Study

Weis E., Waite C., Roelofs K.A.

OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY. 2021 May; 37 (3):S23-S26 10.1097/IOP.0000000000001771

Automatic optimization of treatment dosimetry to improve visual outcomes in episcleral plaque brachytherapy

Han G., Larocque M., Weis E., Menon G.

Brachytherapy. 2021 March; 20 (2):433-445 10.1016/j.brachy.2020.11.003

Rapid growth of primary uveal melanoma following intravitreal bevacizumab injection: a case report and review of the literature

Ma J., Roelofs K.A., Russell L., Weis E., Chen S.H.

DOJ: Digital Ophthalmology Journal. 2021 February; 26 (3):27-30 10.5693/djo.02.2020.06.001

Treatment of corticosteroid-resistant thyroid eye disease with subcutaneous tocilizumab

Silkiss R.Z., Paap M.K., Roelofs K.A., Agi J., Weis E.

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE. 2021 February; 56 (1):66-70 10.1016/j.jcjo.2020.07.020

The Alberta standardized orbital technique in the management of spheno-orbital meningiomas

Agi J., Badilla J., Steinke D., Mitha A.P., Weis E.

EUROPEAN JOURNAL OF OPHTHALMOLOGY. 2020 October; 10.1177/1120672120960332

Two Cases of Giant Melanocytoma (Hyperpigmented Magnocellular Nevus)

Sia D.I.T., Agi J., Grewal P., Russell L., Weis E.

Ocular Oncology and Pathology. 2020 October; 6 (5):344-352 10.1159/000507399